Magnetic resonance spectroscopy: current and future applications in psychiatric research.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biological Psychiatry

• Publication date

  2002-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0006-3223(01)01313-0PMID 11839362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains

  2004cited by this paper
• GABA and mood disorders

  2003cited by this paper
• Magnetization transfer of fluoxetine in the human brain using fluorine magnetic resonance spectroscopy.

  2001cited by this paper
• Brain lithium concentrations in bipolar disorder patients: preliminary (7)Li magnetic resonance studies at 3 T.

  2001cited by this paper
• Functional imaging studies: linking mind and basic neuroscience.

  2001cited by this paper
• Comparison of fMRI and PEPSI during language processing in children

  2001cited by this paper
• Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy.

  2001cited by this paper
• Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder

  2001cited by this paper
• Magnetic resonance spectroscopy. Bridging the neurochemistry and neuroanatomy of schizophrenia.

  2000cited by this paper
• Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia.

  2000cited by this paper
• Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia

  2000cited by this paper
• Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.

  2000cited by this paper
• Heritability heightens brain metabolite differences in schizophrenia.

  2000cited by this paper
• Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

  2000cited by this paper
• Lithium-induced increase in human brain grey matter.

  2000cited by this paper
• The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.

  2000cited by this paper
• Magnetic resonance spectroscopy of brain in epilepsy

  2000cited by this paper
• Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations.

  2000cited by this paper
• Proton magnetic resonance spectroscopy of human basal ganglia: response to cocaine administration

  2000cited by this paper
• Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia.

  2000cited by this paper
• Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.

  2000cited by this paper
• Effects of a phonologically driven treatment for dyslexia on lactate levels measured by proton MR spectroscopic imaging.

  2000cited by this paper
• Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

  2000cited by this paper
• Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study.

  2000cited by this paper
• Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

  2000cited by this paper
• Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia.

  2000cited by this paper
• Effect of chronic psychosocial stress and long-term cortisol treatment on hippocampus-mediated memory and hippocampal volume: a pilot-study in tree shrews.

  2000cited by this paper
• Brain Pharmacokinetics and Tissue Distribution In Vivo of Fluvoxamine and Fluoxetine by Fluorine Magnetic Resonance Spectroscopy

  2000cited by this paper
• Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report.

  2000cited by this paper
• The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review.

  2000cited by this paper
• Chemical mapping of anxiety in the brain of healthy humans: An in vivo 1H‐MRS study on the effects of sex, age, and brain region

  2000cited by this paper
• Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy.

  2000cited by this paper
• Applications of (7)Li NMR in biomedicine.

  2000cited by this paper
• Brain lithium measurements with (7)Li magnetic resonance spectroscopy (MRS): a literature review.

  2000cited by this paper
• Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study.

  2000cited by this paper
• [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].

  2000cited by this paper
• In Vivo Effects of Adenosine A1 Receptor Agonist and Antagonist on Neuronal and Astrocytic Intermediary Metabolism Studied with Ex Vivo 13C NMR Spectroscopy

  2000cited by this paper
• [Magnetic resonance spectroscopy in schizophrenia].

  2000cited by this paper
• Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

  2000cited by this paper
• Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex.

  2000cited by this paper
• Cerebral Metabolism of Lactate in Vivo: Evidence for Neuronal Pyruvate Carboxylation

  2000cited by this paper
• Magnetic resonance spectroscopy

  2000cited by this paper
• Applications of 7Li NMR in biomedicine

  2000cited by this paper
• Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.

  2000cited by this paper
• Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies

  2000cited by this paper
• Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.

  2000cited by this paper
• Magnetic Resonance Spectroscopy and Schizophrenia: What have we Learnt?

  2000cited by this paper
• N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD.

  2000cited by this paper
• Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

  2000cited by this paper
• Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.

  1999cited by this paper
• Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.

  1999cited by this paper
• In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics.

  1999cited by this paper
• Haloperidol Improves Membrane Phospholipid Abnormalities in Temporal Lobes of Schizophrenic Patients

  1999cited by this paper
• Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder

  1999cited by this paper
• Brain N-acetyl aspartate concentrations measured by H MRS are reduced in adult male rats subjected to perinatal stress: preliminary observations and hypothetical implications for neurodevelopmental disorders.

  1999cited by this paper
• Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy.

  1999cited by this paper
• Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

  1999cited by this paper
• Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy.

  1999cited by this paper
• Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain

  1999cited by this paper
• Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy

  1999cited by this paper
• Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic.

  1999cited by this paper
• Proton Magnetic Resonance Spectroscopy in the Frontal and Temporal Lobes of Neuroleptic Naive Patients with Schizophrenia

  1999cited by this paper
• The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

  1999cited by this paper
• Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance.

  1999cited by this paper
• Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression

  1999cited by this paper
• Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users.

  1999cited by this paper
• Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders.

  1999cited by this paper
• Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS.

  1999cited by this paper
• Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive–compulsive disorder

  1999cited by this paper
• Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

  1999cited by this paper
• A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

  1999cited by this paper
• Dyslexic children have abnormal brain lactate response to reading-related language tasks.

  1999cited by this paper
• Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers.

  1999cited by this paper
• Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder

  1998cited by this paper
• Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors

  1998cited by this paper
• In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat‐related posttraumatic stress disorder

  1998cited by this paper
• Measurements of human cerebral GABA at 4.1 T using numerically optimized editing pulses

  1998cited by this paper
• Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

  1998cited by this paper
• 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients

  1998cited by this paper
• Magnetic Resonance Spectroscopy Guided Brain Tumor Resection: Differentiation Between Recurrent Glioma and Radiation Change in Two Diagnostically Difficult Cases

  1998cited by this paper
• Chronic Neuropsychological sequelae in a case of severe lithium intoxication.

  1998cited by this paper
• Topiramate increases cerebral GABA in healthy humans

  1998cited by this paper
• A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects.

  1998cited by this paper
• Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders

  1998cited by this paper
• Towards a method for automated classification of 1H MRS spectra from brain tumours

  1998cited by this paper
• Quantitation of dexfenflurainine/d‐norfenfluramine concentration in primate brain using 19F NMR spectroscopy

  1998cited by this paper
• Magnetic resonance spectroscopy in affective disorders.

  1998cited by this paper
• Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder.

  1998cited by this paper
• Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder

  1998cited by this paper
• Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.

  1998cited by this paper
• Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS

  1998cited by this paper
• Proton magnetic resonance spectroscopy and schizophrenia

  1998cited by this paper
• Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder.

  1998cited by this paper
• 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.

  1997cited by this paper
• 1H-Spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the striatum

  1997cited by this paper
• Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.

  1997cited by this paper
• Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum.

  1997cited by this paper
• Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

  1997cited by this paper
• Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study.

  1997cited by this paper
• 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum.

  1997cited by this paper

• Progress in the application of molecular imaging in psychiatric disorders

  2023cites this paper
• Quantification of short echo time MRS signals with improved version of QUantitation based on quantum ESTimation algorithm

  2023cites this paper
• Protective role of ellagic acid and taurine against fluoxetine induced hepatotoxic effects on biochemical and oxidative stress parameters, histopathological changes, and gene expressions of IL-1β, NF-κB, and TNF-α in male Wistar rats.

  2022cites this paper
• Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies

  2022cites this paper
• Evaluation of the Protective Effects of Ellagic Acid and Taurine on Lipid Pro le and Gene Expressions of NF-κB, IL-1β, and TNF-α against Fluoxetine Induced Hepatotoxicity in Male Wistar Rats

  2021cites this paper
• Measurement of Post-Treatment Changes in Brain Metabolites in Patients with Generalized Anxiety Disorder using Magnetic Resonance Spectroscopy

  2020cites this paper
• Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: a combined SPECT and MRS study.

  2020cites this paper
• Effect of Adjuvant Electroconvulsive Therapy Compared to Antipsychotic Medication Alone on the Brain Metabolites of Patients with Chronic Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study

  2018influential citation
• Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQ.

  2018cites this paper
• Neuroimaging Studies in Psychotic Disorders

  2018cites this paper
• Neuroimaging the Effectiveness of Substance Use Disorder Treatments

  2016cites this paper
• Imaging Techniques for Evaluation of Drug Distribution in Solid Tumor

  2016cites this paper
• 1H-magnetic resonance spectroscopy in first episode and chronic schizophrenia patients.

  2016cites this paper
• Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study.

  2016cites this paper
• Measuring pHi and pHe by MRS

  2015cites this paper
• The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders

  2015cites this paper
• Kapitel 10 – Schizophrenien und andere psychotische Störungen

  2015cites this paper
• Mechanisms in social anxiety disorder in the context of early developmental trauma : an imaging, neurocognitive and genetics study

  2015cites this paper
• Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight☆

  2014cites this paper
• Molecular Imaging for Depressive Disorders

  2014cites this paper
• Quantification in magnetic resonance spectroscopy based on semi-parametric approaches

  2014cites this paper
• Antidepressants act directly on astrocytes: evidences and functional consequences.

  2013cites this paper
• Correction: Altered Reward Circuitry in the Norepinephrine Transporter Knockout Mouse

  2013cites this paper
• Decreased frontal lobe function in people with Internet addiction disorder

  2013cites this paper
• Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents

  2013cites this paper
• Altered Reward Circuitry in the Norepinephrine Transporter Knockout Mouse

  2013cites this paper
• Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

  2012cites this paper
• Neurodegenerative evidences during early onset of depression in CMS rats as detected by proton magnetic resonance spectroscopy at 7 T.

  2012cites this paper
• Lack of an association between obsessive-compulsive disorder and polymorphisms in the 3' untranslated region of GRIN2B in a Chinese Han population.

  2012cites this paper
• Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke

  2011cites this paper
• Readdressing synaptic pruning theory for schizophrenia

  2011cites this paper
• N-acetyl aspartate concentration is correlated with severity of generalized anxiety disorder

  2011cites this paper
• Protein Binding of Drugs

  2011cites this paper
• A Potential Role for Creatine in Drug Abuse?

  2011cites this paper
• Microdialysis Versus Imaging Techniques for In Vivo Drug Distribution Measurements

  2011cites this paper
• Creatine, Brain Functioning, and Behavior

  2011cites this paper
• Advances in the treatment of anxiety: Targeting glutamate

  2011cites this paper
• Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy

  2011cites this paper
• Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.

  2011cites this paper
• Hippocampal neurochemistry is involved in the behavioural effects of neonatal maternal separation and their reversal by post-weaning environmental enrichment: a magnetic resonance study.

  2011cites this paper
• Altered Neurocircuitry in the Dopamine Transporter Knockout Mouse Brain

  2010influential citation
• A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder

  2010cites this paper
• Direct analysis of lipids and small metabolites in mouse brain tissue by AP IR-MALDI and reactive LAESI mass spectrometry.

  2010cites this paper
• Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats.

  2010cites this paper
• Review: Magnetic Resonance Spectroscopy Studies of Pediatric Major Depressive Disorder

  2010cites this paper
• High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression.

  2010cites this paper
• Neuroimaging and Electrophysiology Studies in Major Depressive Disorder

  2009cites this paper
• Reward circuitry is perturbed in the absence of the serotonin transporter

  2009cites this paper
• Clinical applications of neuroimaging for treating depressive disorders.

  2009cites this paper
• Magnetic Resonance Spectroscopy

  2009cites this paper
• Kapitel 10 – Schizophrenien und andere psychotische Störungen

  2009cites this paper
• Magnetic resonance assays of haloperidol in human serum albumin

  2009cites this paper
• Magnetic resonance spectroscopy.

  2008cites this paper
• Auditory processing of sine tones before, during and after ECT in depressed patients by fMRI

  2008cites this paper
• Magnetic resonance imaging and spectroscopy in a mouse model of schizophrenia.

  2008cites this paper
• Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy

  2008cites this paper
• Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy.

  2008cites this paper
• Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study

  2008cites this paper
• The Integration of Positron Emission Tomography With Magnetic Resonance Imaging

  2008cites this paper
• Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.

  2008cites this paper
• Influence of measured and simulated basis sets on metabolite concentration estimates

  2008cites this paper
• SONU20176289, a compound combining partial dopamine D(2) receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression.

  2008cites this paper
• Research Applications of Magnetic Resonance Spectroscopy to Investigate Psychiatric Disorders

  2008cites this paper
• Fluorine magnetic resonance in vivo: a powerful tool in the study of drug distribution and metabolism.

  2008cites this paper
• The Discovery and Development of Pharmacotherapy for Psychiatric Disorders: A Critical Survey of Animal and Translational Models and Perspectives for Their Improvement

  2008cites this paper
• 1H MRS: What the Practicing Clinician Needs to Know

  2008cites this paper
• Imaging Evidence for Pathological Brain Development in Autism Spectrum Disorders

  2008cites this paper
• Use of non-invasive neuroradiological methods in research of psychoactive drugs.

  2007cites this paper
• Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression.

  2007cites this paper
• The study on estimation of time since death with proton magnetic resonance spectroscopy under different temperature

  2007cites this paper
• Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.

  2007cites this paper
• Molecular neuroimaging: from conventional to emerging techniques.

  2007cites this paper
• Making sense of neuroimaging in psychiatry

  2007cites this paper
• Sleep deprivation and brain energy metabolism : in vivo studies in rats and humans

  2007cites this paper
• Alteration of brain metabolites in young alcoholics without structural changes

  2007cites this paper
• Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study.

  2007cites this paper
• Lack of efficacy of 5 grams daily of creatine in schizophrenia: a randomized, double-blind, placebo-controlled trial.

  2007cites this paper
• Torill Eidhammer Sjøbakk MR determined brain metabolic pattern in patients with brain metastases and adolescents with low birth weight

  2007cites this paper
• Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.

  2006cites this paper
• Preliminary findings of proton magnetic resonance spectroscopy in occipital cortex during sleep deprivation.

  2006cites this paper
• Natural linewidth chemical shift imaging (NL‐CSI)

  2006cites this paper
• Metabolic brain imaging by magnetic resonance

  2006cites this paper
• Iconography : Estimation of metabolite concentrations of healthy mouse brain by magnetic resonance spectroscopy at 7 T

  2006cites this paper
• Lesion location in depression post traumatic brain injury using magnetic resonance spectroscopy: Preliminary results from a pilot study

  2006cites this paper
• Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution

  2006cites this paper
• Neuroimaging in neuropsychiatry.

  2005cites this paper
• Functional MRI in pediatric neurobehavioral disorders.

  2005cites this paper
• Time‐domain semi‐parametric estimation based on a metabolite basis set

  2005cites this paper
• Effects of Mirtazapine on Hippocampal Metabolites of Female Patients with Major Depression

  2005cites this paper
• Magnetic resonance spectroscopic studies of pediatric mood disorders: a selective review

  2005cites this paper
• Decreased prefrontal Myo-inositol in major depressive disorder.

  2005cites this paper
• Measurement of Brain Metabolites by 1H Magnetic Resonance Spectroscopy in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

  2005cites this paper
• Metabolite concentrations of healthy mouse brain by Magnetic Resonance Spectroscopy at 7 Tesla

  2005cites this paper
• Imaging technologies in drug development: Anxiety and depression.

  2005cites this paper
• Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.

  2004cites this paper
• Methods to assess tissue-specific distribution and metabolism of drugs.

  2004cites this paper
• [Magnetic resonance spectroscopy (MRS) applications in bipolar disorder].

  2004cites this paper
• Brain metabolic alterations in medication-free patients with bipolar disorder.

  2004cites this paper
• Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

  2004cites this paper
• Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study.

  2004cites this paper